Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

DNTH holding history

Dianthus Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNTH overviewAll 13F holders of DNTHFull Q2 2026 holdings

Shares (Q2 2026)
1,140,260
Value
$111.2M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of DNTH by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,140,260$111.2M<0.1%+358,978+45.9%AddedHolders
Q1 2026781,282$65.6M<0.1%+174,662+28.8%AddedHolders
Q4 2025606,620$25.0M<0.1%+469,547+342.6%AddedHolders
Q3 2025137,073$5.39M<0.1%+5,592+4.3%AddedHolders
Q2 2025131,481$2.45M<0.1%+84,052+177.2%AddedHolders
Q1 202547,429$860.4K<0.1%−6,432−11.9%ReducedHolders
Q4 202453,861$1.17M<0.1%+25,433+89.5%AddedHolders
Q3 202428,428$778.4K<0.1%+20,019+238.1%AddedHolders
Q2 20248,409$217.6K<0.1%−6,096−42.0%ReducedHolders
Q1 202414,505$435.1K<0.1%+14,125+3,717.1%AddedHolders
Q4 2023380$3.95K<0.1%+61+19.1%AddedHolders
Q3 2023319$4.36K<0.1%−380−54.3%ReducedConverted for a 1-for-16 splitHolders
Q2 202311,177$8.47K<0.1%+8,380+299.6%AddedHolders
Q1 20232,797$2.22K<0.1%+2,797NewHolders
Q4 20220$00.0%−8,264−100.0%Sold outHolders
Q3 20228,264$12.0K<0.1%+8,264NewHolders
Q1 20220$00.0%−7,222−100.0%Sold outHolders
Q4 20217,222$32.0K<0.1%+7,185+19,418.9%AddedHolders
Q3 202137$00.0%−120−76.4%ReducedHolders
Q2 2021157$2.00K<0.1%−1,242−88.8%ReducedHolders
Q1 20211,399$17.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.